Brief: India's Balaxi Pharmaceuticals Dec-Quarter Consol Net Profit Falls
Feb 1 (Reuters) - Balaxi Pharmaceuticals Ltd BALX.NS :
* INDIA'S BALAXI PHARMACEUTICALS LTD DEC-QUARTER CONSOL NET
PROFIT
82.3 MILLION RUPEES VERSUS 121.8 MILLION RUPEES
* BALAXI PHARMACEUTICALS LTD DEC-QUARTER CONSOL REVENUE FROM
OPERATIONS 865.8 MILLION RUPEES VERSUS 617.2 MILLION RUPEES
Source text for Eikon: ID:nNSE1cVqG1
Further company coverage: BALX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Balaxi Pharmaceuticals
See all newsBrief: Balaxi Pharmaceuticals Received WHO-GMP Certification For Jadcherla Facility
India's Balaxi Pharma up after Africa, Latam expansion
Brief: Balaxi Pharmaceuticals Expands Global Reach With Hospital Partnerships In Angola
Brief: Balaxi Pharmaceuticals To Set Up Pharmaceutical Formulation Plant In A Phased Manner
Brief: Balaxi Pharmaceuticals Approves Set Up Of First Pharmaceutical Formulation Plant At Jadcherla, Hyderabad